SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-027745
Filing Date
2022-11-18
Accepted
2022-11-18 16:22:02
Documents
15
Period of Report
2022-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20221118_8k.htm   iXBRL 8-K 32206
2 EXHIBIT 1.1 ex_449033.htm EX-1.1 226089
3 EXHIBIT 5.1 ex_449034.htm EX-5.1 8921
  Complete submission text file 0001437749-22-027745.txt   460450

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20221118.xsd EX-101.SCH 3602
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20221118_def.xml EX-101.DEF 11917
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20221118_lab.xml EX-101.LAB 15957
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20221118_pre.xml EX-101.PRE 12128
9 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20221118_8k_htm.xml XML 2639
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 221402215
SIC: 2834 Pharmaceutical Preparations